|
Special clinical interests:
|
|
Catheter based heart valve therapies -
Trans-catheter Aortic Valve Replacement/ Implantation (TAVI or
TAVR)
Coronary Intervention including complex
angioplasty, bifurcation disease, rotational atherectomy.
intravascular imaging
Primary and secondary prevention of
coronary artery disease
Cardiac imaging including Cardiac CT,
PET/CT
|
|
|
Professional profile/background:
|
|
My primary clinical cardiology training
was in Edinburgh, where I undertook a highly successful PhD,
followed by training in interventional and general cardiology.
Subsequently, I undertook advanced interventional coronary
and TAVI fellowship in Vancouver Island, Canada as British
Interventional Society Fellow. My research in vulnerable plaques
has led to several presentations, publications and grants. Indeed,
our research contributions, our research team was invited to the
Buckingham Palace for The Queen's Anniversary Prize for Research
and Higher Education.
During these years, I have been recipient of several
awards including the Josephine Lansdell Award for
research in heart disease. I have presented my
research at the highly prestigious European Society of Cardiology
Hotline sessions in Barcelona and was chosen as the Thomas J.
Linnemeier Spirit of Interventional Cardiology Young Investigator
Finalist at TCT in 2016 Denver, USA. I was a finalist at the Young
Investigator Awards at the American College of Cardiology
Scientific Sessions, San Francisco and Advanced Coronary
Intervention - BCIS, and the BCS in London.
My current post at the Bristol Heart
Institute involves high procedural volume and I currently undertake
over 250 percutaneous coronary interventions and over 100
transcatheter aortic valve implantations annually.
I am also active academically as
honorary senior lecture at the University of Bristol and was
recently awarded the highly competitive Clinical Academic Research
Partnership Award by the Medical Research Council looking at use of
artificial intelligence and machine learning to assess outcomes in
patients with heart disease.
I believe in empowering patients with current clinical
evidence about their condition, so that they can make a well
informed decisions about the treatment options available to
them.
|
|
|
